MENU
AXGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

AXGN stock forecast, quote, news & analysis

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair... Show more

AXGN
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for AXGN with price predictions
Jun 15, 2026

AXGN in upward trend: price may ascend as a result of having broken its lower Bollinger Band on June 01, 2026

AXGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 34 cases where AXGN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 05, 2026. You may want to consider a long position or call options on AXGN as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AXGN just turned positive on June 11, 2026. Looking at past instances where AXGN's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AXGN advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AXGN moved out of overbought territory on May 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AXGN entered a downward trend on June 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.506) is normal, around the industry mean (10.971). P/E Ratio (0.000) is within average values for comparable stocks, (63.498). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.715). AXGN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (8.757) is also within normal values, averaging (23.956).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Dividends

AXGN paid dividends on February 12, 2010

Axogen AXGN Stock Dividends
А quarterly dividend of $1.00 per share was paid with a record date of February 12, 2010, and an ex-dividend date of January 27, 2010. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.43B. The market cap for tickers in the group ranges from 1.86K to 154.45B. ABT holds the highest valuation in this group at 154.45B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -1%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was -15%. TLSI experienced the highest price growth at 31%, while ICCM experienced the biggest fall at -40%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -34%. For the same stocks of the Industry, the average monthly volume growth was 17% and the average quarterly volume growth was 180%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 76
Price Growth Rating: 61
SMR Rating: 90
Profit Risk Rating: 95
Seasonality Score: 25 (-100 ... +100)
View a ticker or compare two or three
AXGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of products and technologies for peripheral nerve reconstruction and regeneration

Industry MedicalNursingServices

Profile
Details
Industry
Medical Specialties
Address
13631 Progress Boulevard
Phone
+1 386 462-6800
Employees
622
Web
https://www.axogeninc.com
AXGN in upward trend: price may ascend as a result of having broken its lower Bollinger Band on June 01, 2026